JP2007513948A - 視神経損傷および網膜損傷の処置のためのスーパーオキシドジスムターゼ模倣物 - Google Patents
視神経損傷および網膜損傷の処置のためのスーパーオキシドジスムターゼ模倣物 Download PDFInfo
- Publication number
- JP2007513948A JP2007513948A JP2006543859A JP2006543859A JP2007513948A JP 2007513948 A JP2007513948 A JP 2007513948A JP 2006543859 A JP2006543859 A JP 2006543859A JP 2006543859 A JP2006543859 A JP 2006543859A JP 2007513948 A JP2007513948 A JP 2007513948A
- Authority
- JP
- Japan
- Prior art keywords
- group
- substituted
- alkyl
- heterocycloalkenyl
- cycloalkenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52883003P | 2003-12-11 | 2003-12-11 | |
| PCT/US2004/039830 WO2005060974A1 (en) | 2003-12-11 | 2004-11-30 | Superoxide dismutase mimics for the treatment of optic nerve and retinal damage |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007513948A true JP2007513948A (ja) | 2007-05-31 |
| JP2007513948A5 JP2007513948A5 (cg-RX-API-DMAC7.html) | 2007-07-26 |
Family
ID=34710102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006543859A Pending JP2007513948A (ja) | 2003-12-11 | 2004-11-30 | 視神経損傷および網膜損傷の処置のためのスーパーオキシドジスムターゼ模倣物 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20070060557A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1691815A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2007513948A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20060101501A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1889961A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2004305531B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0417549A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2545762A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA06006187A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2006124746A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005060974A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200603347B (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1889961A (zh) * | 2003-12-11 | 2007-01-03 | 爱尔康公司 | 用于治疗视神经和视网膜损伤的超氧化物歧化酶拟似物 |
| KR100724586B1 (ko) | 2005-12-09 | 2007-06-04 | 세종대학교산학협력단 | 수퍼옥사이드 디스뮤타아제 활성을 갖는 고리화합물 |
| US8598150B1 (en) | 2008-04-02 | 2013-12-03 | Jonathan R. Brestoff | Composition and method for affecting obesity and related conditions |
| US8987245B2 (en) | 2008-04-02 | 2015-03-24 | Jonathan R. Brestoff Parker | Composition and method for affecting obesity and related conditions |
| US20190388548A1 (en) * | 2018-06-26 | 2019-12-26 | Tzu Chi University | Method for providing ocular neuroprotection or for preventing, treating or alleviating the effects of, an ocular disease associated with retinal ganglion cell death |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10507743A (ja) * | 1994-08-24 | 1998-07-28 | フアーマシア・アンド・アツプジヨン・アー・ベー | 薬剤投与のための方法と手段 |
| JP2002506445A (ja) * | 1997-06-20 | 2002-02-26 | ジー.ディー.サール アンド カンパニー | スーパーオキシドラジカルの不均化反応のための合成触媒を用いる鎮痛方法 |
| JP2003509423A (ja) * | 1999-09-16 | 2003-03-11 | フアルマシア・コーポレーシヨン | スーパーオキシドジスムターゼ活性を有する置換型ピリジノペンタアザ大環錯体 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4550022A (en) * | 1981-10-05 | 1985-10-29 | Alcon Laboratories, Inc. | Tissue irrigating solution |
| DE3773926D1 (de) * | 1987-07-22 | 1991-11-21 | Farvalsa Ag | Feuchtigkeitsstabile feste valproinsaeure-zubereitung und verfahren zu ihrer herstellung. |
| US6127356A (en) * | 1993-10-15 | 2000-10-03 | Duke University | Oxidant scavengers |
| US5994339A (en) * | 1993-10-15 | 1999-11-30 | University Of Alabama At Birmingham Research Foundation | Oxidant scavengers |
| AU5251999A (en) | 1998-08-04 | 2000-02-28 | Wisconsin Alumni Research Foundation | Method of reducing retinal ganglion cell degeneration |
| GB9817845D0 (en) * | 1998-08-17 | 1998-10-14 | Glaxo Group Ltd | Chemical compounds |
| WO2000023568A2 (en) | 1998-10-06 | 2000-04-27 | Albert Einstein College Of Medicine Of Yeshiva University | Methods and compositions for decreasing mitochondrial overproduction of reactive oxygen species in cells |
| ES2240101T3 (es) | 1999-05-27 | 2005-10-16 | Monsanto Company | Biomateriales modificados con mimeticos de superoxido dismutasa. |
| DE60231246D1 (de) * | 2001-12-14 | 2009-04-02 | Alcon Inc | Superoxiddismutas-mimetika zur behandlung von augenerkrankungen |
| CN1889961A (zh) * | 2003-12-11 | 2007-01-03 | 爱尔康公司 | 用于治疗视神经和视网膜损伤的超氧化物歧化酶拟似物 |
-
2004
- 2004-11-30 CN CNA2004800367477A patent/CN1889961A/zh active Pending
- 2004-11-30 RU RU2006124746/14A patent/RU2006124746A/ru not_active Application Discontinuation
- 2004-11-30 EP EP04812365A patent/EP1691815A4/en not_active Withdrawn
- 2004-11-30 BR BRPI0417549-2A patent/BRPI0417549A/pt not_active IP Right Cessation
- 2004-11-30 KR KR1020067010078A patent/KR20060101501A/ko not_active Ceased
- 2004-11-30 MX MXPA06006187A patent/MXPA06006187A/es unknown
- 2004-11-30 JP JP2006543859A patent/JP2007513948A/ja active Pending
- 2004-11-30 US US10/575,911 patent/US20070060557A1/en not_active Abandoned
- 2004-11-30 WO PCT/US2004/039830 patent/WO2005060974A1/en not_active Ceased
- 2004-11-30 US US11/000,213 patent/US20050130951A1/en not_active Abandoned
- 2004-11-30 CA CA002545762A patent/CA2545762A1/en not_active Abandoned
- 2004-11-30 AU AU2004305531A patent/AU2004305531B2/en not_active Ceased
- 2004-11-30 ZA ZA200603347A patent/ZA200603347B/xx unknown
-
2010
- 2010-12-17 US US12/971,143 patent/US20110105453A1/en not_active Abandoned
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10507743A (ja) * | 1994-08-24 | 1998-07-28 | フアーマシア・アンド・アツプジヨン・アー・ベー | 薬剤投与のための方法と手段 |
| JP2002506445A (ja) * | 1997-06-20 | 2002-02-26 | ジー.ディー.サール アンド カンパニー | スーパーオキシドラジカルの不均化反応のための合成触媒を用いる鎮痛方法 |
| JP2003509423A (ja) * | 1999-09-16 | 2003-03-11 | フアルマシア・コーポレーシヨン | スーパーオキシドジスムターゼ活性を有する置換型ピリジノペンタアザ大環錯体 |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2004305531A1 (en) | 2005-07-07 |
| WO2005060974A1 (en) | 2005-07-07 |
| AU2004305531B2 (en) | 2009-11-26 |
| EP1691815A4 (en) | 2010-03-31 |
| US20070060557A1 (en) | 2007-03-15 |
| US20110105453A1 (en) | 2011-05-05 |
| US20050130951A1 (en) | 2005-06-16 |
| CN1889961A (zh) | 2007-01-03 |
| ZA200603347B (en) | 2009-02-25 |
| MXPA06006187A (es) | 2006-08-25 |
| CA2545762A1 (en) | 2005-07-07 |
| EP1691815A1 (en) | 2006-08-23 |
| KR20060101501A (ko) | 2006-09-25 |
| RU2006124746A (ru) | 2008-01-20 |
| BRPI0417549A (pt) | 2007-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8003635B2 (en) | Superoxide dismutase mimics for the treatment of ocular disorders and diseases | |
| CA2505608A1 (en) | Superoxide dismutase mimics for the treatment of ocular disorders and diseases | |
| US8067405B2 (en) | Superoxide dismutase mimics for the treatment of ocular disorders and diseases | |
| US20110105453A1 (en) | Superoxide Dismutase Mimics For The Treatment Of Optic Nerve And Retinal Damage | |
| AU2002351267B8 (en) | Superoxide dismutase mimics for the treatment of ocular disorders and diseases | |
| HK1069785B (en) | Superoxide dismutase mimics for the treatment of ocular disorders and diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070606 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070606 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100921 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20101220 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20101228 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20110314 |